QEII Health Sciences Center, Halifax NS B3H 3A7, Canada.
Foot Ankle Int. 2011 Dec;32(12):1155-63. doi: 10.3113/FAI.2011.1155.
The goal of this study was to design a RSA marker insertion protocol to evaluate the stability of the bone-implant interface of a TAA prosthesis, and to validate that this marker insertion protocol can be combined with MBRSA technology to provide clinically adequate precision in assessing the micromotion of the TAA prosthesis.
The Mobility™ Total Ankle System was used in this study. A marker placement protocol was developed with a Phantom Protocol. The Improved Marker Placement Protocol was used in 20 patients. Postoperative RSA double exams were taken. Condition Numbers (CN) were used to assess the marker distribution. The system precision was defined as the standard deviation of the double exams (MTE, MRE). MBRSA software was used to evaluate the double exams.
The RSA marker insertion technique for the 20 {\it in vivo} cases provided satisfactory results. CNs in all subjects but one were below 50 mm(-1) and implied a desirable marker configuration. The tibial sphere MTE was 0.07 mm and the talar was 0.09 mm. The talar MRE was 0.51 degrees.
The system precision for these {\it in vivo} TAA implants was within the normal range identified by RSA studies, and comparable to the existing TAA RSA studies. This study demonstrated a reliable RSA marker insertion technique in both the tibia and talus. The study confirms that the insertion and MBRSA technique allows the typical high precision demonstrated in other RSA studies (standard deviation less than or equal to 0.25 mm or 0.6 degrees).
This method may allow more accurate assessment of prosthetic subsidence clinically.
本研究旨在设计一种 RSA 标记物植入方案,以评估 TAA 假体的骨-假体界面稳定性,并验证该标记物植入方案可与 MBRSA 技术相结合,从而在评估 TAA 假体微动方面提供足够的临床精度。
本研究使用 Mobility™全踝关节系统。采用 Phantom 方案制定了标记物放置方案。20 例患者采用改良标记物放置方案。术后行 RSA 双次检查。条件数(CN)用于评估标记物分布。系统精度定义为双次检查的标准差(MTE、MRE)。使用 MBRSA 软件评估双次检查。
20 例 {\it 体内} 病例的 RSA 标记物植入技术获得了满意的结果。除 1 例外,所有患者的 CN 均低于 50mm(-1),表明标记物配置理想。胫骨球体 MTE 为 0.07mm,距骨为 0.09mm。距骨 MRE 为 0.51 度。
这些 {\it 体内} TAA 植入物的系统精度在 RSA 研究确定的正常范围内,与现有的 TAA RSA 研究相当。本研究在胫骨和距骨中均证明了可靠的 RSA 标记物植入技术。研究证实,插入和 MBRSA 技术允许在其他 RSA 研究中表现出典型的高精度(标准偏差小于或等于 0.25mm 或 0.6 度)。
该方法可能允许更准确地评估临床上假体下沉。